Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Pediatrics|November 18, 2009
Cardiopulmonary resuscitation for bradycardia with poor perfusion versus pulseless cardiac arrestAaron Donoghue, Robert A Berg, Mary Fran Hazinski, et al.Journal of Neurotrauma|March 31, 2009
A neprilysin polymorphism and amyloid-beta plaques after traumatic brain injuryVictoria E Johnson, William Stewart, David I Graham, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|January 31, 2026
Severity bands for atopic dermatitis measures: Analysis from adult dupilumab randomized clinical trialsAndreas Wollenberg, Eric L Simpson, Yael A Leshem, et al.JAMA Pediatrics|November 8, 2016
Survival Rates Following Pediatric In-Hospital Cardiac Arrests During Nights and WeekendsFarhan Bhanji, Alexis A Topjian, Vinay M Nadkarni, et al.American Journal of Clinical Dermatology|November 11, 2025
Efficacy and Safety of Dupilumab in Adults with Prurigo Nodularis with or Without Atopic Comorbidities: A Subgroup Analysis from Two Randomized Phase III Clinical TrialsBrian S Kim, Margarida Gonçalo, Tsukasa Ugajin, et al.American Journal of Clinical Dermatology|April 17, 2026
Identifying the Most Relevant Eczema Area and Severity Index Thresholds from the Patient Perspective in Atopic Dermatitis TreatmentLawrence F Eichenfield, Peter A Lio, Alan D Irvine, et al.Dermatology and Therapy|May 12, 2026
Dupilumab Treatment Provides Multidimensional Benefits in Patients with Prurigo NodularisSonja Ständer, Gil Yosipovitch, Shawn G Kwatra, et al.Paediatric Drugs|April 2, 2026
Long-Term Safety and Efficacy of Dupilumab Treatment in Children Aged 6 Months to 5 Years with Severe Atopic DermatitisAmy S Paller, Andreas Pinter, Lara Wine Lee, et al.Dermatology and Therapy|September 19, 2025
Optimal Itch Response in Adults Treated with Dupilumab for Moderate-to-Severe Atopic DermatitisSonja Ständer, Gil Yosipovitch, Brian S Kim, et al.Dermatology and Therapy|July 11, 2025
Dupilumab versus Lebrikizumab Demonstrates Greater Likelihood of Achieving and Maintaining Improvements in Efficacy Outcomes Using a Placebo-Adjusted Indirect Treatment ComparisonSonja Ständer, Andreas Pinter, Firas G Hougeir, et al.Pageof 2